Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Abstract

Cancer cells establish replicative immortality by activating a telomere-maintenance mechanism (TMM), be it telomerase or the alternative lengthening of telomeres (ALT) pathway. Targeting telomere maintenance represents an intriguing opportunity to treat the vast majority of all cancer types. Whilst telomerase inhibitors have historically been heralded as promising anticancer agents, the reality has been more challenging, and there are currently no therapeutic options for cancer types that use ALT despite their aggressive nature and poor prognosis. In this Review, we discuss the mechanistic differences between telomere maintenance by telomerase and ALT, the current methods used to detect each mechanism, the utility of these tests for clinical diagnosis, and recent developments in the therapeutic strategies being employed to target both telomerase and ALT. We present notable developments in repurposing established therapeutic agents and new avenues that are emerging to target cancer types according to which TMM they employ. These opportunities extend beyond inhibition of telomere maintenance, by finding and exploiting inherent weaknesses in the telomeres themselves to trigger rapid cellular effects that lead to cell death.

• Authors: Jixuan Gao, Hilda A Pickett
• Journal: Nature reviews. Cancer (Nat Rev Cancer) Vol. 22 Issue 9 Pg. 515-532 (09 2022) ISSN: 1474-1768 [Electronic] England
• PMID: 35790854 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
• Copyright: © 2022. Springer Nature Limited.

Chemical References

• Telomerase

Topics

• DNA Replication
• Humans
• Neoplasms (drug therapy, genetics)
• Telomerase (genetics)
• Telomere (genetics, metabolism)
• Telomere Homeostasis